Associated Papers
Immunologic and Genetic Contributors to CD46-Dependent Immune Dysregulation.
Meyer BJ et al.
Journal of Clinical Immunology, 2023
Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study.
Brocklebank V et al.
Blood, 2023
37369098 (PubMed )
Supplement: BLOOD_BLD-2022-018833R2-mmc1.pdf
A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activity.
Rossio R et al.
Haematologica, 2015
Eculizumab for dense deposit disease and C3 glomerulonephritis.
Bomback AS et al.
Clinical Journal of the American Society of Nephrology : Cjasn, 2012
A rare pathogenic MCP mutation in patient with congenital TTP.
Masnic F et al.
Hematology, Transfusion and Cell Therapy, 0
Recurrent C3 Glomerulonephritis with an ADAMTS 13 Gene Variant: A Case Report and Literature Review.
Zahrani RAA et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 0
Select a paper to view details